m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0127)
Name |
Exposure to radiation
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: PH73
|
Full List of Target Gene(s) of This m6A-centered Disease Response
DNA polymerase kappa (Pol Kappa/POLK)
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | Methylation at the 6 position of adenosine (m6A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 and the demethylase FTO. DNA DNA polymerase kappa (Pol Kappa/POLK), which has been implicated in both nucleotide excision repair and trans-lesion synthesis, required the catalytic activity of METTL3 for immediate localization to ultraviolet-induced DNA damage sites. | |||
Responsed Disease | Exposure to radiation [ICD-11: PH73] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | DNA repair | |||
Nucleotide excision repair (hsa03420) | ||||
In-vitro Model | A-375 | Amelanotic melanoma | Homo sapiens | CVCL_0132 |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
MEF (Mouse embryonic fibroblasts) | ||||
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | Methylation at the 6 position of adenosine (m6A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 and the demethylase FTO. DNA DNA polymerase kappa (Pol Kappa/POLK), which has been implicated in both nucleotide excision repair and trans-lesion synthesis, required the catalytic activity of METTL3 for immediate localization to ultraviolet-induced DNA damage sites. | |||
Responsed Disease | Exposure to radiation [ICD-11: PH73] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | DNA repair | |||
Nucleotide excision repair (hsa03420) | ||||
In-vitro Model | A-375 | Amelanotic melanoma | Homo sapiens | CVCL_0132 |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
MEF (Mouse embryonic fibroblasts) | ||||
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |